跳至主要内容
临床试验/2024-513057-78-00
2024-513057-78-00招募中4 期

Frozen Shoulder Treatment with IA Corticosteroid Injection and Suprascapular Nerve Block

UZ Brussel1 个研究点 分布在 1 个国家目标入组 156 人开始时间: 2024年9月16日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
UZ Brussel
入组人数
156
试验地点
1
主要终点
The key primary endpoint is the change in shoulder-related disability 3 months after intervention vs control, assessed through a validated questionnaire the Shoulder Pain and Disability Index (SPADI).

研究概览

简要总结

The aim of this study is to determine if there is any difference in pain relief and function in patients with Frozen Shoulder when given an Gleno-Humeral (GH) IACI with a SSNB compared to an GH IACI with a sham SSNB.

In another part of the study, we will try to determine which set of clinical examination tests and/or MRI criteria has the best diagnostic accuracy in early-stage Frozen Shoulder.

Finally, we want to identify which patients will benefit most from GH IACI or the combination of GH IACI and SSNB. The results of this trial will help to guide clinical practice treating patients with FS and improve resource allocation. The key primary endpoint is the change in shoulder-related disability 3 months after intervention vs control, assessed through a validated questionnaire the Shoulder Pain and Disability Index (SPADI).

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Written informed consent to participate in the study must be obtained from the subject prior to initiation of any study-mandated procedure
  • Suffering from Frozen Shoulder, defined as: Frozen shoulder is a self-limiting disease characterized by pain and functional restriction in both active and passive shoulder motion lasting more than 1 month, for which radiographic findings of the shoulder joint are unremarkable.
  • Dutch or French speaking persons
  • Age ≥ 18 years
  • Control subjects for the diagnostic accuracy part of the study protocol: Subjects suffering from shoulder pain that do not fulfill the diagnostic criteria of Frozen Shoulder
  • Control subjects for the diagnostic accuracy part of the study protocol: Contralateral shoulder of Frozen Shoulder subjects

排除标准

  • Subjects with posttraumatic or postsurgical stiff shoulder syndrome
  • Psychiatric illness
  • Systematic yeast infections
  • Hypovolaemia
  • Infections at the injection site
  • Medical history of malignant hyperthermia, major conductin disorders, acute cardiac de-compensation, shock conditions, convulsions
  • Subjects who have received prior SSNB in the homolateral shoulder
  • Subjects who have received an IACI in the homolateral shoulder in the 3 months before inclusion
  • History of trauma at the onset of symptoms
  • Subjects with rheumatologic or neurologic disease involving the shoulder
  • Subjects with cervical radiculopathy
  • Subjects with coagulation disorder or treatments with anticoagulants
  • Hypersensitivity to local anesthetics or MRI contrast agent
  • Inability to understand the study procedures

结局指标

主要结局

The key primary endpoint is the change in shoulder-related disability 3 months after intervention vs control, assessed through a validated questionnaire the Shoulder Pain and Disability Index (SPADI).

The key primary endpoint is the change in shoulder-related disability 3 months after intervention vs control, assessed through a validated questionnaire the Shoulder Pain and Disability Index (SPADI).

次要结局

  • • An intermediary statistical analysis will be performed at 6 months. In case all 3 outcomes (disability, pain, shoulder stiffness) show non-superiority at 6m, the study will not be ex-tended to the 12-month time point.
  • Pain - Numeric Pain Rating Scale (NPRS) [Time Frame: 4 weeks - 3months - 6months - 12months after the intervention]
  • SPADI [Time Frame: 4 weeks- 6 months - 12months after the intervention]
  • Constant - Murley score (CMS) [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Health related quality of life, evaluated with the EuroQol EQ-5D 3L [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • PROMIS-29 Upper Extremity v2.0- Physical function [Time Frame: 4weeks - 3 months - 6 months - 12 months after the intervention]
  • Shoulder ROM in abduction, anterior elevation, external rotation [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Coracoid Pain Test (CPT): The pain severity approach and affected-unaffected approach of the instrument-assisted CPT, as described by Mertens et al. (2022) are used.
  • Distension Test in Passive External Rotation (DTPER): as described by Noboa et al. in 2015 in Revista Esponola De Cirurgia Ortopedica Y Traumatologia [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Strict passive GH abduction: The patient is seated upright in a chair to limit trunk extension, the scapula and acromion are blocked with one hand of the examiner, while the other hand slowly brings the patient’s arm in maximal abduction, while the patient’s elbow is maintained in 90° flexion. [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Jobe Test 32: as described by Jobe et al. in 1982 in AJSM [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Neer Test 33: as described by Neer et al. in 1983 in Clin Rel Orthop Res. [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Hawkins-Kennedy test 34: as described by Hawkins et al. in 1980 in AJSM [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Tampa Scale for Kinesiophobia (TSK-11): [Time Frame: 4weeks - 3 months - 6months - 12months after the intervention]
  • Pain Self-Efficacy Questionnaire (PSEQ) [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Global Rating of Change Score (GRoC) [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Work Ability Index (WAI) [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Work Status [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Healthcare service use [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Adverse effects [Time Frame: 4weeks - 3months - 6months - 12months after the intervention]
  • Use of rescue therapy [Time Frame: 3months - 6months - 12months after the intervention]
  • Exploratory prediction analysis part I: Through regression analysis the investigators want to find out which factors predict I) SPADI score at 3 -6- 12 months follow-up, II) pain NPR level at 3-6-12 months, III) shoulder ROM (°) at 3-6-12 months and IV) return to work and WAI score at 3-6-12 months.
  • Exploratory prediction analysis part II: Through regression analysis the investigators want to identify which physical examination tests, or which combinations of tests are correlated with MRI diagnostic criteria and a more positive evolution of SPADI score – NPR pain score – shoulder ROM (°)– RTW/WAI score
  • Exploratory prediction analysis part III: Through regression analysis the investigators want to identify patients that benefit the most from the combined SSNB + IACI

研究者

发起方
UZ Brussel
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Marc Schiltz

Scientific

UZ Brussel

研究点 (1)

Loading locations...

相似试验